In conjunction with the results of bioinformatics analyses of data obtained from public databases and of our analyses of patient tissue samples, we can conclude that NeuroD1 expression is associated with increased levels of cell differentiation and improved patient outcomes in patients with pancreatic cancer. The gene discussed is NEUROD1; the disease is familial pancreatic carcinoma.